SCHEMBL7146835

SCHEMBL7146835

COc1cccc(C(=O)NCc2ccc([S+]([O-])N3CCC(NCc4cccnc4)CC3)s2)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.48
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
TDP1 Q9NUW8 1/20 0.45
GAA P10253 1/20 0.45
ALDH1A1 P00352 5/20 0.45
KDM4E B2RXH2 2/20 0.45
MAPT P10636 2/20 0.45
HTT P42858 2/20 0.45
MAPK1 P28482 1/20 0.45
CYP1A2 P05177 2/20 0.44
CYP3A4 P08684 2/20 0.44
TSHR P16473 1/20 0.44
BLM P54132 1/20 0.44
L3MBTL1 Q9Y468 2/20 0.43
CYP2C19 P33261 1/20 0.43
USP2 O75604 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
ROCK2 O75116 2/20 0.42
ROCK1 Q13464 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7143055 0.88 DRD4 (0.47) SMN1; SMN2MEN1KMT2AMAPTCYP1A2
SCHEMBL7144914 0.86 KMT2A (0.48) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL7146510 0.86 SENP5 (0.42) SMN1; SMN2MEN1KMT2AALDH1A1MAPT
SCHEMBL7148150 0.86 CHRM1 (0.46) GAAALDH1A1TSHRL3MBTL1CYP2C19
SCHEMBL7147874 0.86 CCR2 (0.44) ALDH1A1KDM4EMMP13
SCHEMBL7146066 0.85 MCHR1 (0.45) SMN1; SMN2MEN1KMT2AALDH1A1KDM4E
SCHEMBL7145387 0.85 LMNA (0.45) GAAALDH1A1TSHRCYP2C19USP2
SCHEMBL3479915 0.84 KMT2A (0.50) SMN1; SMN2MEN1KMT2ATDP1GAA
SCHEMBL7138040 0.84 TACR1 (0.49) SMN1; SMN2RAB9A
SCHEMBL7146457 0.83 CHRM1 (0.43) SMN1; SMN2ALDH1A1TSHRCYP2C19USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1322642-A2 sHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVES BEARING BOTH LIPOPHILIC AND IONISABLE MOIETIES AS INHIBITORS OF PROTEIN JUNKINASES Applied Research Systems ARS Holding N.V. (AN) 2003-07-02 EP claimed
WO-2002026733-A2 sHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVES BEARING BOTH LIPOPHILIC AND IONISABLE MOIETIES AS INHIBITORS OF PROTEIN JUNKINASES APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2002-04-04 WO claimed